Concerns Raised Over FDA, White House Clashes

Industry analysts are concerned that the Obama administration's tendency to overrule FDA's regulatory decisions could diminish the agency's reputation for regulatory integrity and diligence. Daniel Carpenter, an FDA historian at Harvard University, said, "The politicization of the FDA could hurt not only consumer protection but industry profits as well."

• "White House And the FDA Often at Odds" (Harris, New York Times, 4/2).